Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Taichiroh Nishikawa"'
Autor:
Michihisa Moriguchi, Tasuku Hara, Kohichiroh Yasui, Taichiroh Nishikawa, Hironori Mitsuyoshi, Yoshio Sumida, Hiroyoshi Taketani, Hiroshi Ishiba, Akira Okajima, Masahito Minami, Kanji Yamaguchi, Hideki Fujii, Yuya Seko, Yoshito Itoh, Takeshi Nishimura
Publikováno v:
Hepatology Research. 45:E156-E160
A 56-year-old male patient with chronic hepatitis C was treated with pegylated interferon (PEG IFN)-α-2b and ribavirin (RBV) for 72 weeks in 2006. The patient achieved an early virological response (EVR); however, hepatitis C relapsed 12 weeks after
Autor:
Satoru Sekoguchi, Yoshito Itoh, Tatsuo Katagishi, Taichiroh Nishikawa, Michihisa Moriguchi, Hiroyuki Kimura, Takeshi Okanoue, Hidetaka Takashima, Tadashi Watanabe, Masahito Minami, Keizo Kagawa, Tomoki Nakajima
Publikováno v:
Liver International. 25:77-84
Aim: Our aim was to clarify the significance of expression levels and post-transcriptional splicing patterns of survivin during multistep hepatocarcinogenesis and tumor progression. Methods: Using immunohistochemistry, we first elucidated the express
Autor:
Akira, Okajima, Kanji, Yamaguchi, Hiroyoshi, Taketani, Tasuku, Hara, Hiroshi, Ishiba, Yuya, Seko, Takeshi, Nishimura, Taichiroh, Nishikawa, Hideki, Fujii, Michihisa, Moriguchi, Hironori, Mitsuyoshi, Yoshio, Sumida, Kohichiroh, Yasui, Masahito, Minami, Yoshito, Itoh
Publikováno v:
Hepatology research : the official journal of the Japan Society of Hepatology. 45(10)
A 56-year-old male patient with chronic hepatitis C was treated with pegylated interferon (PEG IFN)-α-2b and ribavirin (RBV) for 72 weeks in 2006. The patient achieved an early virological response (EVR); however, hepatitis C relapsed 12 weeks after
Autor:
Hidetaka, Takashima, Tomoki, Nakajima, Michihisa, Moriguchi, Satoru, Sekoguchi, Taichiroh, Nishikawa, Tadashi, Watanabe, Tatsuo, Katagishi, Hiroyuki, Kimura, Masahito, Minami, Yoshito, Itoh, Keizo, Kagawa, Takeshi, Okanoue
Publikováno v:
Liver international : official journal of the International Association for the Study of the Liver. 25(1)
Our aim was to clarify the significance of expression levels and post-transcriptional splicing patterns of survivin during multistep hepatocarcinogenesis and tumor progression.Using immunohistochemistry, we first elucidated the expression of survivin